Pay in 4 interest-free payments of $153.75 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Neuroprotective methodologies in treatment of Multiple Sclerosis: Current status of Clinical and Pre-clinical findings
Neuroprotection and functional recovery after application of the caspase-9 inhibitor z-LEHD-fmk in a rat model of traumatic spinal cord injury
PubMed PMID: 24706397
211555-08-7
2018 May 26
Adalimumab igmine Neuroprotective methodologies in treatment ofAdalimumab is a human monoclonal IgG1 antibody targeting tumour necrosis factor (TNF ). Product information CAS Number: 331731 18 1 Chemical Name: Adalimumab Technical Data Appearance: Solid Power Purity: 98% (or refer to the Certificate of Analysis) Solubility: Soluble in DMSO Shipping Condition: Shipped under ambient temperature as non hazardous chemical or refer to Certificate of Analysis Storage Condition: Dry, dark and 20 oC for 1 year or refer
US$ 17.95
US$ 67500.00
US$ 2570.64
US$ 69.00
US$ 55000.00
US$ 300.62
US$ 198.00
US$ 37000.00
US$ 504.00
US$ 225000.00